SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-006753
Filing Date
2022-06-17
Accepted
2022-06-17 16:45:46
Documents
1
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 form4-06172022_040626.html 4  
1 form4-06172022_040626.xml 4 4005
  Complete submission text file 0001415889-22-006753.txt   5373
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 1LIFE HEALTHCARE, INC. ONE EMBARCADERO CENTER, SUITE 1900 SAN FRANCISCO CA 94111
Business Address
Blumenkranz Mark S. (Reporting) CIK: 0001614869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 221024596